Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | CDC25A | P30304 | 1/20 | 0.49 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.49 |
| ▸ | AKT1 | P31749 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.42 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | PTAFR | P25105 | 1/20 | 0.41 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120088 | 0.96 | ALDH1A1 (0.53) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2117742 | 0.91 | LMNA (0.54) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2120223 | 0.91 | LMNA (0.57) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL15389793 | 0.91 | LMNA (0.47) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2117747 | 0.90 | LMNA (0.60) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL3627911 | 0.90 | LMNA (0.60) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2119799 | 0.90 | LMNA (0.60) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2120824 | 0.90 | LMNA (0.60) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2118513 | 0.90 | LMNA (0.60) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL2120325 | 0.90 | LMNA (0.60) | SMN1; SMN2LMNAESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 912 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12638614-B2 | Method for making silicone hydrogel contact lenses | ALCON INC. (CH) | 2026-05-26 | — | — | US | claimed |
| CN-122057088-A | Nickel-titanium alloy urethral stent with anti-calculus and antibacterial difunctional coating and preparation method thereof | 海南百迈科医疗科技股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-05-14 | — | — | US | claimed |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4713721-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4707877-A2 | METHOD FOR PRODUCING SILICON HYDROGEL CONTACT LENSES WITH CROSSLINKED HYDROPHILIC COATINGS THEREON | Alcon Inc. (CH) | 2026-03-11 | — | — | EP | claimed |
| US-12570784-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-03-10 | — | — | US | claimed |
| EP-4514596-B1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-03-04 | — | — | EP | claimed |
| EP-3759528-B1 | SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-03-04 | — | — | EP | claimed |
| EP-4703480-A1 | SINGLE-STRANDED NUCLEIC ACID ADSORPTION INHIBITOR, NUCLEIC ACID SOLUTION, AND NUCLEIC ACID AMPLIFICATION METHOD | NOF Corporation (JP) | 2026-03-04 | — | — | EP | claimed |
| US-20100093846-A1 | HYDROXAMATE COMPOSITIONS | TYCO HEALTHCARE GROUP LP | 2010-04-15 | — | — | US | claimed |
| US-20100081780-A1 | DIOL (METH) ACRYLATE COMPOUND HAVING URETHANE BOND, METHOD FOR PRODUCING THE SAME, AND POLYMER THEREOF | NOF CORPORATION (JP) | 2010-04-01 | — | — | US | claimed |
| US-20100081779-A1 | DIOL (METH) ACRYLATE COMPOUND HAVING URETHANE BOND, METHOD FOR PRODUCING THE SAME, AND POLYMER THEREOF | NOF CORPORATION (JP) | 2010-04-01 | — | — | US | claimed |
| EP-2160192-A1 | ANTIMICROBIAL MATERIALS AND COATINGS | Tyco Healthcare Group LP (US) | 2010-03-10 | — | — | EP | claimed |
| EP-2160193-A1 | FURANONE COPOLYMERS | Tyco Healthcare Group LP (US) | 2010-03-10 | — | — | EP | claimed |
| EP-2120824-A1 | COATING COMPOSITIONS | Tyco Healthcare Group LP (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008144248-A1 | FURANONE COPOLYMERS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |
| WO-2008144247-A1 | ANTIMICROBIAL MATERIALS AND COATINGS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |
| WO-2008143654-A1 | COATING COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |
| WO-2003040218-A1 | POROUS POLYMER FILMS | POLYMERAT PTY LTD (AU) | 2003-05-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | SMN1; SMN2 4624/4885LMNA 2948/4885ESR1 2368/4885 |
| US-12570784-B2 | Method for making embedded hydrogel contact lenses | CRYAB, CRYZ, CRYAA | SMN1; SMN2 4766/4885LMNA 219/4885ESR1 4484/4885 |
| US-12638614-B2 | Method for making silicone hydrogel contact lenses | SMCHD1, CRYAA, CRYZ | SMN1; SMN2 4315/4885LMNA 1330/4885ESR1 3419/4885 |
| US-20100093846-A1 | HYDROXAMATE COMPOSITIONS | HCAR3, ABHD16A, PLA2G2C | SMN1; SMN2 3890/4885LMNA 3232/4885ESR1 2634/4885 |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | CRYZ, CRYAB, CRYAA | SMN1; SMN2 4239/4885LMNA 1320/4885ESR1 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.